BDA advises Navis on the sale of majority stake in OPV Pharmaceuticals to RV Healthcare

received investment from

a subsidiary of

has acquired

a portfolio company of

has been acquired by

agreed to divest East Syracuse, New York facility to

a portfolio company of

has been acquired by

investment from

has been acquired by

a portfolio company of

has been acquired by

agreed to divest Couvet, Switzerland facility to WuXi AppTec

raised Series B round from

backed by

has been acquired by

divested Escientia Life Sciences to Deccan Fine Chemicals

LAP Lasers a portfolio company of

has been acquired by

divested majority stake to

a portfolio company of

has been acquired by

AGIC and Humanwell

recapitalized majority by

divested CMC Biologics to